Wachovia upgrades BioMed Realty Trust (NYSE: BMR) to Outperform with a $26-$28 valuation range.

The firm said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE